Skip navigation
Home
Research Outputs
Researchers
Organizations
Projects
Explore by
Research Outputs
Researchers
Organizations
Projects
Sign on to:
My Homepage
Receive email
updates
Edit Account details
Browsing by Author
Al Swaff, Reham
Enter a last name
Or, select a letter below to browse by last name
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 1 to 20 of 23
next >
Refman
EndNote
Bibtex
RefWorks
Send via email
Issue Date
Title
Author(s)
Sep-2008
• Assessment of ascitic fluid complement 3 level in cirrhotic patients with and without spontaneous bacterial peritonitis
Al Swaff, Reham
Sep-2015
• Assessment of serum adiponectin in Egyptian patients with HCV‑ related cirrhosis and hepatocellular carcinoma
Al Swaff, Reham
2017
•The Association between Systemic Hypertension and Chronic HCV-4 Infection
Al Swaff, Reham
2014
Cardiac Output Changes in Hepatorenal Syndrome
Al Swaff, Reham
Apr-2017
• Circulating Leptin in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
Al Swaff, Reham
2012
• Correlation between Alanine Aminotransferase level, HCV RNA titer and fibrosis stage in chronic HCV genotype 4 infection
Al Swaff, Reham
2012
• Correlation between level of Viremia and Insulin Resistance in Patients with Chronic Hepatitis C virus genotype 4 Infection
Al Swaff, Reham
2015
• Detection of Occult Hepatitis C Virus Among Healthy Spouses of Patients With HCV Infection
Al Swaff, Reham
2013
• Effect of Prolongation of Combined Treatment in HCV-4 Infection
Al Swaff, Reham
2012
• Effect of Well Controlled Diabetes Mellitus on Sustained Virologic Response in Chronic HCV Genotype 4 Infected Patients
Al Swaff, Reham
2018
• Impact of Diabetic Control on Achieving Sustained Virologic Response in Chronic HCV Patients Receiving Direct-Acting Antivirals
Al Swaff, Reham
2014
• Impact of interferon lambda gene polymorphism on treatment of HCV-4 infection in diabetic patients
Al Swaff, Reham
Jan-2009
Insulin Resistance in Chronic Hepatitis B virus (genotype D) infection
Yehia El Shazly; Raef Malak; Al Swaff, Reham
Oct-2016
• Prediction of Post-operative Mortality in Patients with HCV-related Cirrhosis Undergoing Non-Hepatic Surgeries
Al Swaff, Reham
2014
• Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease Symptoms
Al Swaff, Reham
Aug-2011
• The prevalence of occult hepatitis B infection among hepatitis C virus genotype 4 chronically infected Egyptian patients and its effect on response to combined therapy (pegylated interferon alpha 2 a and ribavirin ) for HCV chronic infection
Al Swaff, Reham
Sep-2010
Relevance of Reptilase time in detection of dysfibrinogenemia in patients with compensated liver disease decompensated liver cirrhosis and hepatocellular carcinoma
Al Swaff, Reham
2013
Response Prediction in Chronic Hepatitis C-4 by Assessment of IL28B-Related Single Nucleotide Polymorphisms (rs12979860, rs12980275, and rs8099917)
Mohamed A. Saber; Ahmed A. Monis; Al Swaff, Reham
Sep-2011
Response to combined treatment in chronic HCV genotype 4 infected patients with persistently normal ALT levels
Al Swaff, Reham
2014
• Serum Calprotectin Level for Diagnosis and Detection of Disease Activity in Rheumatoid Arthritis. International Journal of Immunology
Al Swaff, Reham